398 related articles for article (PubMed ID: 18290858)
1. Relationship between mean blood glucose and glycated haemoglobin in Type 2 diabetic patients.
Makris K; Spanou L; Rambaouni-Antoneli A; Koniari K; Drakopoulos I; Rizos D; Haliassos A
Diabet Med; 2008 Feb; 25(2):174-8. PubMed ID: 18290858
[TBL] [Abstract][Full Text] [Related]
2. The relationship between self-monitored blood glucose values and glycated haemoglobin in insulin-treated patients with Type 2 diabetes.
Sarwat S; Ilag LL; Carey MA; Shrom DS; Heine RJ
Diabet Med; 2010 May; 27(5):589-92. PubMed ID: 20536957
[TBL] [Abstract][Full Text] [Related]
3. Skin intrinsic fluorescence is associated with hemoglobin A(1c )and hemoglobin glycation index but not mean blood glucose in children with type 1 diabetes.
Felipe DL; Hempe JM; Liu S; Matter N; Maynard J; Linares C; Chalew SA
Diabetes Care; 2011 Aug; 34(8):1816-20. PubMed ID: 21636794
[TBL] [Abstract][Full Text] [Related]
4. Hemoglobin Glycosylation Index is not related with blood glucose.
Merino-Torres JF; Fajardo-Montañana C; Ferrer-García JC; Piñón-Sellés F
J Diabetes Complications; 2003; 17(5):249-53. PubMed ID: 12954152
[TBL] [Abstract][Full Text] [Related]
5. Relationship between glycated haemoglobin levels and mean glucose levels over time.
Nathan DM; Turgeon H; Regan S
Diabetologia; 2007 Nov; 50(11):2239-44. PubMed ID: 17851648
[TBL] [Abstract][Full Text] [Related]
6. No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes.
Godbout A; Hammana I; Potvin S; Mainville D; Rakel A; Berthiaume Y; Chiasson JL; Coderre L; Rabasa-Lhoret R
Diabetes Metab; 2008 Dec; 34(6 Pt 1):568-73. PubMed ID: 18922724
[TBL] [Abstract][Full Text] [Related]
7. Fasting plasma glucose 6-12 weeks after starting insulin glargine predicts likelihood of treatment success: a pooled analysis.
Karl D; Zhou R; Vlajnic A; Riddle M
Diabet Med; 2012 Jul; 29(7):933-6. PubMed ID: 22413808
[TBL] [Abstract][Full Text] [Related]
8. Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes.
Kilpatrick ES; Rigby AS; Goode K; Atkin SL
Diabetologia; 2007 Dec; 50(12):2553-61. PubMed ID: 17882397
[TBL] [Abstract][Full Text] [Related]
9. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data.
Pickup JC; Freeman SC; Sutton AJ
BMJ; 2011 Jul; 343():d3805. PubMed ID: 21737469
[TBL] [Abstract][Full Text] [Related]
10. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of injection-meal interval usage and its association with variables of metabolic control in patients with Type 1 and Type 2 diabetes.
Müller N; Kloos C; Frank T; Ristow M; Wolf G; Müller UA
Diabet Med; 2011 Feb; 28(2):223-6. PubMed ID: 21219434
[TBL] [Abstract][Full Text] [Related]
12. Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes.
McCarter RJ; Hempe JM; Gomez R; Chalew SA
Diabetes Care; 2004 Jun; 27(6):1259-64. PubMed ID: 15161772
[TBL] [Abstract][Full Text] [Related]
13. Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).
Murata GH; Shah JH; Hoffman RM; Wendel CS; Adam KD; Solvas PA; Bokhari SU; Duckworth WC;
Diabetes Care; 2003 Jun; 26(6):1759-63. PubMed ID: 12766106
[TBL] [Abstract][Full Text] [Related]
14. A simple way to estimate mean plasma glucose and to identify Type 2 diabetic subjects with poor glycaemic control when a standardized HbA1c assay is not available.
Ozmen S; Cil T; Atay AE; Tuzcu AK; Bahceci M
Diabet Med; 2006 Oct; 23(10):1151-4. PubMed ID: 16978383
[TBL] [Abstract][Full Text] [Related]
15. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
Blonde L; Merilainen M; Karwe V; Raskin P;
Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
[TBL] [Abstract][Full Text] [Related]
16. Is HbA(1c) affected by glycemic instability?
Derr R; Garrett E; Stacy GA; Saudek CD
Diabetes Care; 2003 Oct; 26(10):2728-33. PubMed ID: 14514571
[TBL] [Abstract][Full Text] [Related]
17. Does glucose variability influence the relationship between mean plasma glucose and HbA1c levels in type 1 and type 2 diabetic patients?
Kuenen JC; Borg R; Kuik DJ; Zheng H; Schoenfeld D; Diamant M; Nathan DM; Heine RJ;
Diabetes Care; 2011 Aug; 34(8):1843-7. PubMed ID: 21700921
[TBL] [Abstract][Full Text] [Related]
18. Glycated haemoglobin or mean blood glucose as indicators of metabolic control in Type 2 diabetes?
Pupillo M; De Berardis G; Antenucci D; Minnucci A; Nicolucci A
Diabetes Res Clin Pract; 2008 Jun; 80(3):e1-3. PubMed ID: 18258329
[TBL] [Abstract][Full Text] [Related]
19. Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control.
Bonora E; Calcaterra F; Lombardi S; Bonfante N; Formentini G; Bonadonna RC; Muggeo M
Diabetes Care; 2001 Dec; 24(12):2023-9. PubMed ID: 11723077
[TBL] [Abstract][Full Text] [Related]
20. Relationship between glycosylated haemoglobin and mean plasma glucose concentration in cystic fibrosis.
Brennan AL; Gyi KM; Wood DM; Hodson ME; Geddes DM; Baker EH
J Cyst Fibros; 2006 Jan; 5(1):27-31. PubMed ID: 16202666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
